Brief: Nanoform Announces New Midterm Business Targets For 2030
Dec 16 (Reuters) - Nanoform Finland Oyj NANOFH.HE: ANNOUNCES NEW MIDTERM BUSINESS TARGETS FOR 2030 NEW BUSINESS TARGET: 3 NANOFORMED MEDICINES LAUNCHED BY 2030 NEW BUSINESS TARGET: INCOME GROWTH >50% CAGR 2026-2030 NEW BUSINESS TARGET: EBIT MARGIN >30% BY 2030 Source text: ID:nMFN3wS2wP Further company coverage: NANOFH.HE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Nanoform Finland Oyj
See all newsFinland's Nanoform Q2 EBITDA loss narrows on layoffs, cost cuts
Brief: Nanoform Q2 EBITDA EUR -3 Million
Brief: Nanoform Receives Positive Feedback From UK Mhra Scientific Advice Meeting
Finland's Nanoform Q1 revenue rises 45%, EBITDA loss narrows
Brief: Nanoform Finland Targets Cash Burn Below EUR 10 Mln For 2026